Clinical Trial Update: A Study of KHK4827 in Patients With Systemic Sclerosis [Phase 1]

View source ↗

Summary

The Phase 1 trial of KHK4827 in systemic sclerosis has completed. No results are provided in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• KHK4827

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Systemic Sclerosis | Phase 1 | Status: COMPLETED